Canada markets close in 4 hours 28 minutes

AN2 Therapeutics, Inc. (ANTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5740-0.0160 (-0.62%)
As of 11:25AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
54,871
54,871
29,511
16,906
6,019
Selling General and Administrative
14,764
14,764
12,751
4,668
1,265
Total Operating Expenses
69,635
69,635
42,262
21,574
7,284
Operating Income or Loss
-69,635
-69,635
-42,262
-21,574
-7,284
Total Other Income/Expenses Net
4,903
4,903
1,306
-38
-6,322
Income Before Tax
-64,732
-64,732
-40,956
-21,543
-13,603
Income from Continuing Operations
-64,732
-64,732
-40,956
-21,543
-13,603
Net Income
-64,732
-64,732
-40,956
-21,543
-13,603
Net Income available to common shareholders
-64,732
-64,732
-42,776
-28,058
-13,603
Basic EPS
-2.80
-
-2.79
-1.55
-0.97
Diluted EPS
-2.80
-
-2.79
-1.55
-0.97
Basic Average Shares
20,999
-
15,340
18,140
14,048
Diluted Average Shares
20,999
-
15,340
18,140
14,048